Proteogenix

From Wikipedia, the free encyclopedia
Jump to: navigation, search

Proteogenix is a corporation based in Portland, Oregon, United States, that develops and markets biomarker diagnostic tests for the detection of life-threatening pregnancy-related conditions. Proteogenix is currently developing non-invasive protein biomarker screening tests for intra-amniotic infection, premature birth, and Down syndrome, which combined cause 175,000 premature births each year in the United States alone.[1]

References[edit]

  1. ^ "ProteoGenix News from The BioSpace Beat". Biospace.com. September 29, 2004. 

External links[edit]